Monday, March 1, 2021

Cipla gets USFDA nod for migraine drug

Cipla gets USFDA nod for migraine drug The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline#39;s Imitrex Nasal Spray.

from Moneycontrol Business News https://ift.tt/2OhK3rC

No comments:

Post a Comment

Oil prices may face further pressure amid OPEC+ supply glut: Seth R Freeman

Seth R Freeman of GlassRatner Advisory notes India's role in stabilizing oil prices by purchasing discounted Russian oil amidst tariff a...